Patent · US Active

CD19 binding agents and uses thereof

US8242252B2 · kind B2 · utility

16Cited by
15References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2011
Grant dateAug 14, 2012
Priority date—
Expiry dateMay 17, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to CD 19 binding agents and methods of using such CD 19 binding agents for treating disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.